In the SF-767 cancer cell line, both samples at IC50 values demonstrated a 1.5 to 2-fold reduction in PD-L1 expression (p ≤ 0.0001) while maintaining consistently high PTEN expression levels (Fig 20). The gene discussed is PTEN; the disease is cancer.